TSO3 to Disclose First Quarter 2013 Financial Results and Hold Annual General Meeting of Shareholders May 8, 2013

Ticker:  TSX - TOS
Shares Outstanding: 72,888,182

QUEBEC CITY, April 29, 2013 /CNW Telbec/ - TSO₃ Inc. ("TSO₃") (TSX: TOS) will report first quarter (Q1) 2013 financial results, for the period ending March 31, 2013 via press release on Wednesday May 8, 2013. TSO₃ will also hold its fiscal 2012 Annual General Meeting of Shareholders at 3:00 P.M. (EDST) the same day.

The Annual General Meeting of Shareholders will be held at the McCord Museum (J. Armand-Bombardier Theatre), 690 Sherbrooke Street West, Montreal (Québec) at 3:00 P.M. (EDST).

Interested parties will be able to listen to the live webcasts of the Annual General Meeting of Shareholders via CNW's website at http://www.newswire.ca/en/webcast/detail/1135279/1238559. The webcast will then be archived for a 90-day period.

About TSO₃

TSO₃, founded in Québec City in 1998, specializes in the research and development of innovative, high-performance medical instrument sterilization technology with high commercial potential. TSO₃ designs products for sterile processing areas in the hospital environment and offers an advantageous replacement solutions to other low temperature sterilization processes currently used in hospitals. For more information about TSO₃, visit the Company's Web site at www.tso3.com

The statements in this release and oral statements made by representatives of TSO₃ relating to matters that are not historical facts (including, without limitation, those regarding the timing or outcome of any financing undertaken by TSO₃) are forward-looking statements that involve certain risks, uncertainties and hypotheses, including, but not limited to, general business and economic conditions, the condition of the financial markets, the ability of TSO₃ to obtain financing on favourable terms and other risks and uncertainties.

The TSX has neither approved nor disapproved the information contained herein and accepts no responsibility for it.

SOURCE: TSO3 Inc.

Caroline Côté
Director - Investor and Business Relations
418 651-0003, Ext. 237
[email protected]